EYPT Research and Charts

EYPT - EyePoint Pharmaceuticals Inc (Healthcare: Biotechnology)

Projected Earnings Date: 0000-02-29 (Delayed quote data 2025-04-04)

Last 4.61	Change ⇓ -0.38 (-7.62%)	Volume 1,596,165
	Open 4.78	High 5.10	Low 4.51

8EMA (Daily) 5.32	40EMA (Daily) 6.30	50EMA (Daily) 6.49	STO (Daily) 7.976	MACD Hist (Daily) -0.278
8EMA (Weekly) 6.116	40EMA (Weekly) 8.62	50EMA (Weekly) 9.14	STO (Weekly) 18.431	MACD Hist (Weekly) -0.217


Company Profile
EyePoint Pharmaceuticals Inc is a pharmaceutical company. It is engaged in developing and commercializing ophthalmic products for the treatment of eye diseases. The company has developed 5 FDA-approved sustained-release treatments in ophthalmology. Its pre-clinical development program is focused on using its core Durasert and Verisome Technology platforms to deliver drugs to treat wet age-related macular degeneration, glaucoma, osteoarthritis, and other diseases. Geographically, the firm has operational footprints in the U.S., China, and the UK. It generates a majority of its revenue from the U.S.

Disclaimer: All information provided is for informational purposes only and not intended for trading purposes or advice. The quotes and charts are not real time and have delays of at least 20 minutes. Data accuracy cannot be guaranteed as errors will occur. Please do not rely on the above information to make your stock/option trades. Neither OptionChance.com nor any of independent data providers is liable for any informational errors, incompleteness, or delays, or for any actions taken in reliance on information contained herein.